Two Sigma Investments, LP In8 Bio, Inc. Put Options Transaction History
Two Sigma Investments, LP
- $40.3 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding INAB
# of Institutions
33Shares Held
8.64MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD2.87MShares$2.3 Million1.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$1.14 Million0.0% of portfolio
-
Ensign Peak Advisors, Inc Salt Lake City, UT1.12MShares$894,6120.0% of portfolio
-
683 Capital Management, LLC New York, NY615KShares$491,8030.06% of portfolio
-
Sigma Planning Corp Ann Arbor, MI515KShares$412,0640.02% of portfolio
About IN8BIO, INC.
- Ticker INAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,502,200
- Market Cap $19.6M
- Description
- IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of...